ArticleCureus2025
Venovenous Extracorporeal Membrane Oxygenation for Alveolar Hemorrhage During Mitral Valve Repair via Right Minithoracotomy in a Patient With Myelodysplastic Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac surgery in patients with myelodysplastic syndrome (MDS) is difficult because extracorporeal circulation increases the risk of infection and hemorrhage. We discuss the efficacy of venovenous extracorporeal membrane oxygenation (VV-ECMO) in managing intraoperative alveolar hemorrhage in a patient with MDS undergoing minimally invasive cardiac surgery (MICS) for mitral valve repair. A 76-year-old man with MDS underwent mitral valve repair via right minithoracotomy with standard cardiopulmonary bypass. Left lung hemorrhage developed after declamping of the aorta, and oxygenation support was necessary when the cardiopulmonary bypass was finished, as a bridge until hemostasis. VV-ECMO was established, which involves withdrawing blood from the right femoral vein and returning it via the right internal jugular vein. Platelet transfusion and protamine were administered. Hemostasis was achieved, and the patient was admitted to the intensive care unit without mechanical circulatory support. VV-ECMO proved successful for MICS with hemorrhagic pulmonary complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.